Key result
The SCVL automated device accurately measured ankle-brachial index compared to Doppler ultrasound, detecting abnormal ABI with a mean difference of 0.010.
Why the study?
Does the SCVL automated device accurately measure the ankle-brachial index compared to the Doppler-assisted method in patients with increased cardiovascular risk?
Cross-Sectional (n=157)
Does the SCVL automated device accurately measure the ankle-brachial index compared to the Doppler-assisted method in patients with increased cardiovascular risk?
Answers are grounded in this paper and cite their sources.
The SCVL automated device provides accurate and reproducible ankle-brachial index measurements comparable to the gold standard Doppler method, potentially easing peripheral arterial disease screening.
OBJECTIVE: To evaluate the accuracy of the ankle brachial index (ABI) measured with the SCVL(®) ("screening cardiovascular lab"; GenNov, Paris, France), an automated device with synchronized arm and ankle cuffs with an automatic ABI calculation. METHODS: Patients were consecutively included in a cardiovascular prevention unit if they presented with at least two cardiovascular risk factors. ABI measurements were made using the SCVL, following a synchronized assessment of brachial and ankle systolic pressure. These values were compared to the ABI obtained with the usual Doppler-assisted method. RESULTS: We included 157 patients. Mean age was 59.1 years, 56.8% had hypertension, 22.3% had diabetes mellitus, and 17.6% were current smokers. An abnormal ABI was observed in 17.2% with the SCVL and in 16.2% with the Doppler. The prevalence rates of an abnormal ABI by patient measured with each device, ie, 15.7% (confidence interval [CI] 0.95: [11.8; 20.4]) or 14.3% (CI 0.95: [10.7; 18.9]), did not differ. The coefficient of variation of Doppler and SCVL measures was 15.8% and 15.1%, respectively. The regression line between the two measurement methods was statistically significant. The value-to-value comparison also shows a difference of mean equal to 0.010 (CI 0.95: [-0.272; 0.291]) (r = -0.055). Reproducibility of ABI measurements with the SCVL showed a difference of mean equal to 0.009 (CI 0.95: [-0.203; 0.222]), without heteroscedasticity (r = -0.003). CONCLUSION: The SCVL is a fast and easy to use automated oscillometric device for the determination of ABI. The use of this two-synchronized-cuff device correlates well with the gold standard Doppler ultrasound method and is reproducible. The SCVL may ease the screening for peripheral arterial disease in routine medical practice.
No takes yet. Share an insight, caveat, or question.
Rosenbaum et al. (2012) conducted a cross-sectional in Increased cardiovascular risk (n=157). SCVL automated device vs. Doppler-assisted method was evaluated on Prevalence of an abnormal ABI by patient (Mean difference 0.010, 95% CI -0.272 to 0.291). The SCVL automated device accurately measured ankle-brachial index compared to Doppler ultrasound, detecting abnormal ABI with a mean difference of 0.010.
Synapse has enriched 10 related papers. Consider them for comparative context: